ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M, 2011. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 49: 785–798.
-
2.
Knox KS, Hage CA, 2010. Histoplasmosis. Proc Am Thorac Soc 7: 169–172.
-
3.
Goodwin RA, Loyd JE, Prez RMD, 1981. Histoplasmosis in normal hosts. Medicine (Baltimore) 4: 231–266.
-
4.
Wheat J, 1995. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 8: 146–159.
-
5.
Deepe GS, 2015. Histoplasma capsulatum. Bennett JE, Dolin R, Blaser MJ, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier, 2949–2962.
-
6.
Cáceres DH, Gómez BL, Restrepo Á, Tobón ÁM, 2012. Histoplasmosis y sida: factores de riesgo clínico y de laboratorio asociados al pronóstico de la enfermedad. Infectio 16 (Suppl 3): 44–50.
-
7.
Desai SS, Wong B, 2007. Diagnostic immunology. Hospenthal DR, Rinaldi MG, eds. Diagnosis and Treatment of Human Mycoses. Totowa, NJ: Humana Press, 53–80.
-
8.
Kauffman CA, 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115–132.
-
9.
Scheel CM, Gómez BL, 2014. Diagnostic methods for histoplasmosis: focus on endemic countries with variable infrastructure levels. Curr Trop Med Rep 1: 129–137.
-
10.
Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S, 2013. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 7: e2319.
-
11.
Carmona-Fonseca J, 1971. Análisis estadístico y ecológico-epidemiológico de la sensibilidad a la histoplasmina en Colombia 1950–1968. Antioquia Med 21: 109–154.
-
12.
Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, Linares M, Valencia Y, Restrepo A; Colombian Histoplasmosis Study Group, 2011. Histoplasmosis: results of the Colombian National Survey, 1992–2008. Biomedica 31: 344–356.
-
13.
Arango-Bustamante K, Restrepo A, Cano LE, Bedout C, Tobón AM, González A, 2013. Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg 89: 937–942.
-
14.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813–1821.
-
15.
Muñoz C, Gómez BL, Tobón A, Arango K, Restrepo A, Correa MM, Muskus C, Cano LE, González A, 2010. Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America. Clin Vaccine Immunol 17: 62–67.
-
16.
Kaufman M, Huppert CF, Netto L, Pollak A, Restrepo A, 1974. Manual of Standardized Serodiagnostic Procedures for Systemic Mycoses. Part 2: Complement Fixation Tests. Washington, DC: Departmant of Research, Development and Coordination, Pan American Health Organization.
-
17.
Kaufman L, Huppert M, Fava-Neto C, Negroni R, Restrepo A, 1974. Manual of Standardized Serodiagnostic Procedures for Systemic Mycosis Part I: Agar Gel Immunodiffusion Tests. Washington, DC: Departmant of Research, Development and Coordination, Pan American Health Organization.
-
18.
Lindsley MD, Morrison CJ, Warnock DW, 2007. Serological and molecular diagnosis of fungal infections. Detrick B, Hamilton RJ, eds. Manual of Molecular and Clinical Laboratory Immunology, 7th edition. Washington, DC: ASM Press, 569–605.
-
19.
Caceres DH, Scheel CM, Tobón AM, Ahlquist Cleveland A, Restrepo A, Brandt ME, Chiller T, Gómez BL, 2014. Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clin Vaccine Immunol 9: 1364–1368.
-
20.
Lopes-Mori FM, Mitsuka-Breganó R, Capobiango JD, Inoue IT, Reiche EM, Morimoto HK, Casella AM, Bittencourt LH, Freire RL, Navarro IT, 2011. Programs for control of congenital toxoplasmosis. Rev Assoc Med Bras 57: 594–599.
-
21.
Golding GR, Quinn B, Bergstrom K, Stockdale D, Woods S, Nsungu M, Brooke B, Levett PN, Horsman G, McDonald R, Szklarczuk B, Silcox S, Paton S, Carson M, Mulvey MR, Irvine J; Northern Antibiotic Resistance Partnership, 2012. Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in northern Saskatchewan, Canada. BMC Public Health 6: 12–15.
-
22.
Masanza MM, Nqobile N, Mukanga D, Gitta SN, 2010. Laboratory capacity building for the International Health Regulations (IHR[2005]) in resource-poor countries: the experience of the African Field Epidemiology Network (AFENET). BMC Public Health 10 (Suppl 1): S8.
-
23.
Monday B, Gitta SN, Wasswa P, Namusisi O, Bingi A, Musenero M, Mukanga D, 2011. Paradigm shift: contribution of field epidemiology training in advancing the “One Health” approach to strengthen disease surveillance and outbreak investigations in Africa. Pan Afr Med J 10 (Suppl 1): 13.
-
24.
Mukanga D, Tshimanga M, Wurapa F, Binka F, Serwada D, Bazeyo W, Pariyo G, Wabwire-Mangen F, Gitta S, Chungong S, Trostle M, Nsubuga P, 2011. The genesis and evolution of the African Field Epidemiology Network. Pan Afr Med J 10 (Suppl 1): 2.
-
25.
Mosha F, Oundo J, Mukanga D, Njenga K, Nsubuga P, 2011. Public health laboratory systems development in east Africa through training in laboratory management and field epidemiology. Pan Afr Med J 10 (Suppl 1): 14.
-
26.
Kuonza L, Tint KS, Harris B, Nabukenya I, 2011. Public health systems strengthening in Africa: the role of South Africa Field Epidemiology and Laboratory Training Programme. Pan Afr Med J 10 (Suppl 1): 8.
-
27.
Wakai K, Matsuo K, 2007. The JICA training course, community-based cancer prevention for the Asian and Pan-Pacific countries, fiscal year 2006 (epidemiological approach). Asian Pac J Cancer Prev 8: 150–154.
-
28.
SIVIGILA Instituto Nacional de Salud (INS), 2014. Boletín epidemiológico semana 14 del año 2014. Available at: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2014%20Boletin%20epidemiologico%20semana%2014.pdf. Accessed April 7, 2014.
-
29.
Palacio D, Rodríguez C, Cuervo C, Echeverri R, Mendez C, Urquijo L, 2010. Informe UNGASS-2010. Seguimiento de la Declaración de compromiso sobre el VIH/sida, Informe Nacional, Republica de Colombia. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2010countries/colombia_2010_country_progress_report_en.pdf. Accessed March 8, 2010.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 299 | 252 | 22 |
| Full Text Views | 441 | 8 | 0 |
| PDF Downloads | 140 | 6 | 0 |
Implementation of a Training Course Increased the Diagnosis of Histoplasmosis in Colombia
Diego H. Caceres
Diego H. Caceres
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Diego H. Caceres in
Current site
Google Scholar
PubMed
Search for other papers by Diego H. Caceres in
Current site
Google Scholar
PubMed
Alejandra Zuluaga
Alejandra Zuluaga
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Alejandra Zuluaga in
Current site
Google Scholar
PubMed
Search for other papers by Alejandra Zuluaga in
Current site
Google Scholar
PubMed
Karen Arango-Bustamante
Karen Arango-Bustamante
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Karen Arango-Bustamante in
Current site
Google Scholar
PubMed
Search for other papers by Karen Arango-Bustamante in
Current site
Google Scholar
PubMed
Catalina de Bedout
Catalina de Bedout
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Catalina de Bedout in
Current site
Google Scholar
PubMed
Search for other papers by Catalina de Bedout in
Current site
Google Scholar
PubMed
Ángela Maria Tobón
Ángela Maria Tobón
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Ángela Maria Tobón in
Current site
Google Scholar
PubMed
Search for other papers by Ángela Maria Tobón in
Current site
Google Scholar
PubMed
Ángela Restrepo
Ángela Restrepo
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Ángela Restrepo in
Current site
Google Scholar
PubMed
Search for other papers by Ángela Restrepo in
Current site
Google Scholar
PubMed
Beatriz L. Gómez
Beatriz L. Gómez
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Beatriz L. Gómez in
Current site
Google Scholar
PubMed
Search for other papers by Beatriz L. Gómez in
Current site
Google Scholar
PubMed
Luz Elena Cano
Luz Elena Cano
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Luz Elena Cano in
Current site
Google Scholar
PubMed
Search for other papers by Luz Elena Cano in
Current site
Google Scholar
PubMed
Ángel González
Ángel González
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia; School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia; School of Microbiology, Universidad de Antioquia, Medellín, Colombia; Basic and Applied Microbiology Research Group (MICROBA), School of Microbiology, Universidad de Antioquia, Medellín, Colombia
Search for other papers by Ángel González in
Current site
Google Scholar
PubMed
Search for other papers by Ángel González in
Current site
Google Scholar
PubMed
Histoplasmosis causes a significant mortality, especially persons living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) from developing countries where access to both appropriate diagnostic methods and antiretroviral therapy are limited. A total of 81 physicians assigned to 17 Colombian departments (states) received training in the clinical, epidemiological, and diagnostic aspects of histoplasmosis. Once this training was received and during the period of October 2009–November 2012, these physicians sent biological samples for immunodiagnostic, mycological, and molecular tests from their patients with suspicion of histoplasmosis. A total of 1,536 samples from 768 patients were evaluated. Of the 768 patients studied, 463 (60%) were HIV positive, 214 (28%) HIV negative, and in 91 (12%) this diagnosis was unknown, and 538 (70%) were males. The 1,536 specimens studied comprised 722 sera, 439 blood samples, and 241 urines, which were tested by immunodiffusion (ID), culture, and antigenuria, respectively; in addition, 134 specimens were tested by performing a molecular assay. Histoplasmosis was diagnosed in 133 patients (17%). After the training, we observed more diagnoses from 27 to 44 cases per year. In this study, a significantly increased number of histoplasmosis cases reported by year were observed after implementing an educational training program.
Author Notes
Financial support: This work was supported by Strategy for Sustainability (2013–2014) for Research Groups, University of Antioquia (CODI).
Authors' addresses: Diego H. Caceres, Alejandra Zuluaga, Karen Arango-Bustamante, Catalina de Bedout, Ángela Maria Tobón, Ángela Restrepo, and Luz Elena Cano, Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia, E-mails: diegocaceres84@gmail.com, zuluaga.alejandra@gmail.com, karen.arango@gmail.com, catybedout@gmail.com, atobon@cib.org.co, angelares@une.net.co, and lcano@cib.org.co. Beatriz L. Gómez, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia, and Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Medellin, Colombia, E-mail: beatrizlgomez@hotmail.com. Ángel González, School of Microbiology, Universidad de Antioquia, Medellin, Colombia, E-mail: angelgonzalezmarin1972@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M, 2011. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 49: 785–798.
-
2.
Knox KS, Hage CA, 2010. Histoplasmosis. Proc Am Thorac Soc 7: 169–172.
-
3.
Goodwin RA, Loyd JE, Prez RMD, 1981. Histoplasmosis in normal hosts. Medicine (Baltimore) 4: 231–266.
-
4.
Wheat J, 1995. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 8: 146–159.
-
5.
Deepe GS, 2015. Histoplasma capsulatum. Bennett JE, Dolin R, Blaser MJ, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier, 2949–2962.
-
6.
Cáceres DH, Gómez BL, Restrepo Á, Tobón ÁM, 2012. Histoplasmosis y sida: factores de riesgo clínico y de laboratorio asociados al pronóstico de la enfermedad. Infectio 16 (Suppl 3): 44–50.
-
7.
Desai SS, Wong B, 2007. Diagnostic immunology. Hospenthal DR, Rinaldi MG, eds. Diagnosis and Treatment of Human Mycoses. Totowa, NJ: Humana Press, 53–80.
-
8.
Kauffman CA, 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115–132.
-
9.
Scheel CM, Gómez BL, 2014. Diagnostic methods for histoplasmosis: focus on endemic countries with variable infrastructure levels. Curr Trop Med Rep 1: 129–137.
-
10.
Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S, 2013. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 7: e2319.
-
11.
Carmona-Fonseca J, 1971. Análisis estadístico y ecológico-epidemiológico de la sensibilidad a la histoplasmina en Colombia 1950–1968. Antioquia Med 21: 109–154.
-
12.
Arango M, Castañeda E, Agudelo CI, De Bedout C, Agudelo CA, Tobón A, Linares M, Valencia Y, Restrepo A; Colombian Histoplasmosis Study Group, 2011. Histoplasmosis: results of the Colombian National Survey, 1992–2008. Biomedica 31: 344–356.
-
13.
Arango-Bustamante K, Restrepo A, Cano LE, Bedout C, Tobón AM, González A, 2013. Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg 89: 937–942.
-
14.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813–1821.
-
15.
Muñoz C, Gómez BL, Tobón A, Arango K, Restrepo A, Correa MM, Muskus C, Cano LE, González A, 2010. Validation and clinical application of a molecular method for identification of Histoplasma capsulatum in human specimens in Colombia, South America. Clin Vaccine Immunol 17: 62–67.
-
16.
Kaufman M, Huppert CF, Netto L, Pollak A, Restrepo A, 1974. Manual of Standardized Serodiagnostic Procedures for Systemic Mycoses. Part 2: Complement Fixation Tests. Washington, DC: Departmant of Research, Development and Coordination, Pan American Health Organization.
-
17.
Kaufman L, Huppert M, Fava-Neto C, Negroni R, Restrepo A, 1974. Manual of Standardized Serodiagnostic Procedures for Systemic Mycosis Part I: Agar Gel Immunodiffusion Tests. Washington, DC: Departmant of Research, Development and Coordination, Pan American Health Organization.
-
18.
Lindsley MD, Morrison CJ, Warnock DW, 2007. Serological and molecular diagnosis of fungal infections. Detrick B, Hamilton RJ, eds. Manual of Molecular and Clinical Laboratory Immunology, 7th edition. Washington, DC: ASM Press, 569–605.
-
19.
Caceres DH, Scheel CM, Tobón AM, Ahlquist Cleveland A, Restrepo A, Brandt ME, Chiller T, Gómez BL, 2014. Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clin Vaccine Immunol 9: 1364–1368.
-
20.
Lopes-Mori FM, Mitsuka-Breganó R, Capobiango JD, Inoue IT, Reiche EM, Morimoto HK, Casella AM, Bittencourt LH, Freire RL, Navarro IT, 2011. Programs for control of congenital toxoplasmosis. Rev Assoc Med Bras 57: 594–599.
-
21.
Golding GR, Quinn B, Bergstrom K, Stockdale D, Woods S, Nsungu M, Brooke B, Levett PN, Horsman G, McDonald R, Szklarczuk B, Silcox S, Paton S, Carson M, Mulvey MR, Irvine J; Northern Antibiotic Resistance Partnership, 2012. Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in northern Saskatchewan, Canada. BMC Public Health 6: 12–15.
-
22.
Masanza MM, Nqobile N, Mukanga D, Gitta SN, 2010. Laboratory capacity building for the International Health Regulations (IHR[2005]) in resource-poor countries: the experience of the African Field Epidemiology Network (AFENET). BMC Public Health 10 (Suppl 1): S8.
-
23.
Monday B, Gitta SN, Wasswa P, Namusisi O, Bingi A, Musenero M, Mukanga D, 2011. Paradigm shift: contribution of field epidemiology training in advancing the “One Health” approach to strengthen disease surveillance and outbreak investigations in Africa. Pan Afr Med J 10 (Suppl 1): 13.
-
24.
Mukanga D, Tshimanga M, Wurapa F, Binka F, Serwada D, Bazeyo W, Pariyo G, Wabwire-Mangen F, Gitta S, Chungong S, Trostle M, Nsubuga P, 2011. The genesis and evolution of the African Field Epidemiology Network. Pan Afr Med J 10 (Suppl 1): 2.
-
25.
Mosha F, Oundo J, Mukanga D, Njenga K, Nsubuga P, 2011. Public health laboratory systems development in east Africa through training in laboratory management and field epidemiology. Pan Afr Med J 10 (Suppl 1): 14.
-
26.
Kuonza L, Tint KS, Harris B, Nabukenya I, 2011. Public health systems strengthening in Africa: the role of South Africa Field Epidemiology and Laboratory Training Programme. Pan Afr Med J 10 (Suppl 1): 8.
-
27.
Wakai K, Matsuo K, 2007. The JICA training course, community-based cancer prevention for the Asian and Pan-Pacific countries, fiscal year 2006 (epidemiological approach). Asian Pac J Cancer Prev 8: 150–154.
-
28.
SIVIGILA Instituto Nacional de Salud (INS), 2014. Boletín epidemiológico semana 14 del año 2014. Available at: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2014%20Boletin%20epidemiologico%20semana%2014.pdf. Accessed April 7, 2014.
-
29.
Palacio D, Rodríguez C, Cuervo C, Echeverri R, Mendez C, Urquijo L, 2010. Informe UNGASS-2010. Seguimiento de la Declaración de compromiso sobre el VIH/sida, Informe Nacional, Republica de Colombia. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2010countries/colombia_2010_country_progress_report_en.pdf. Accessed March 8, 2010.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 299 | 252 | 22 |
| Full Text Views | 441 | 8 | 0 |
| PDF Downloads | 140 | 6 | 0 |